215 related articles for article (PubMed ID: 33489804)
1. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD).
Xie T; Li Y; Ying J; Cai W; Li J; Lee KY; Ricciuti B; Pacheco J; Xing P
Transl Lung Cancer Res; 2020 Dec; 9(6):2428-2439. PubMed ID: 33489804
[TBL] [Abstract][Full Text] [Related]
2. Expression of
Zhang SL; Zhang CY; Chen YQ; Li YF; Xie Z; Zhang XC; Zhou Q; Zhong WZ; Huang J; Sun H; Zheng MY; Xiao FM; Yan HH; Lu DX; Lv ZY; Wu YL; Chen HJ; Yang JJ
J Thorac Dis; 2023 Sep; 15(9):4620-4635. PubMed ID: 37868836
[TBL] [Abstract][Full Text] [Related]
3. Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.
Mc Leer A; Foll M; Brevet M; Antoine M; Novello S; Mondet J; Cadranel J; Girard N; Giaj Levra M; Demontrond P; Audigier-Valette C; Letouzé E; Lantuéjoul S; Fernandez-Cuesta L; Moro-Sibilot D
Lung Cancer; 2022 May; 167():98-106. PubMed ID: 35183375
[TBL] [Abstract][Full Text] [Related]
4. Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study.
Ding J; Leng Z; Gu H; Jing X; Song Y
Front Oncol; 2023; 13():1153131. PubMed ID: 37361601
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
[TBL] [Abstract][Full Text] [Related]
6. Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers.
Li J; Wei B; Feng J; Wu X; Chang Y; Wang Y; Yang X; Zhang H; Han S; Zhang C; Zheng J; Groen HJM; van den Berg A; Ma J; Li H; Guo Y
Front Endocrinol (Lausanne); 2022; 13():1006480. PubMed ID: 36583000
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis.
Xu J; Xu L; Wang B; Kong W; Chen Y; Yu Z
Front Oncol; 2021; 11():766148. PubMed ID: 35223450
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study.
Zhang Y; Hao Y; Pan H; Zheng H; Zhou J
J Thorac Dis; 2023 Dec; 15(12):7013-7023. PubMed ID: 38249933
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Wang W; Xu C; Chen H; Jia J; Wang L; Feng H; Wang H; Song Z; Yang N; Zhang Y
Lung Cancer; 2021 May; 155():20-27. PubMed ID: 33714778
[TBL] [Abstract][Full Text] [Related]
10. The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in
Wang Z; Zhang L; Xu W; Li J; Liu Y; Zeng X; Zhong M; Zhu Y
J Inflamm Res; 2022; 15():649-667. PubMed ID: 35140497
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From
Zhang B; Lewis W; Stewart CA; Morris BB; Solis LM; Serrano A; Xi Y; Wang Q; Lopez ER; Concannon K; Heeke S; Tang X; Raso G; Cardnell RJ; Vokes N; Blumenschein G; Elamin Y; Fosella F; Tsao A; Skoulidis F; Hume CB; Sasak K; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Tran H; Zhang J; Gibbons D; Vaporciyan A; Wang J; Park K; Heymach JV; Byers LA; Gay CM; Le X
JTO Clin Res Rep; 2024 Feb; 5(2):100623. PubMed ID: 38357092
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment.
Hwang S; Hong TH; Park S; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YL; Lee SH
Transl Lung Cancer Res; 2021 Nov; 10(11):4209-4220. PubMed ID: 35004251
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer.
Zhang Y; Chen Q; Huang T; Zhu D; Lu Y
Front Med (Lausanne); 2023; 10():1203461. PubMed ID: 37583423
[TBL] [Abstract][Full Text] [Related]
14. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review.
Zhang C; Lin L; Guo X; Chen P
Transl Cancer Res; 2020 May; 9(5):3725-3733. PubMed ID: 35117735
[TBL] [Abstract][Full Text] [Related]
15. Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases.
Ahn S; Hwang SH; Han J; Choi YL; Lee SH; Ahn JS; Park K; Ahn MJ; Park WY
J Pathol Transl Med; 2016 Jul; 50(4):258-63. PubMed ID: 27160687
[TBL] [Abstract][Full Text] [Related]
16. Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.
Lu Y; Li Z; Zhu H; Zhao J; Xu M; Gu W
Ann Palliat Med; 2021 Dec; 10(12):12886-12893. PubMed ID: 35016432
[TBL] [Abstract][Full Text] [Related]
17.
Takuma S; Inoue Y; Karayama M; Tsuchiya K; Tsukui H; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
JTO Clin Res Rep; 2022 Jan; 3(1):100264. PubMed ID: 35005656
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma.
Wang S; Xie T; Hao X; Wang Y; Hu X; Wang L; Li Y; Li J; Xing P
Thorac Cancer; 2021 Oct; 12(19):2585-2593. PubMed ID: 34490724
[TBL] [Abstract][Full Text] [Related]
19. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA
J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622
[TBL] [Abstract][Full Text] [Related]
20. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
